Zobrazeno 1 - 10
of 13
pro vyhledávání: '"J A, Skirvin"'
Autor:
Houry Leblebjian, Sylvia Bartel, Donna Neuberg, Anne M. McDonnell, Daniel J. DeAngelo, Richard Stone, Lillian Werner, Martha Wadleigh, J. Andrew Skirvin
Publikováno v:
Leukemia Research. 37:747-751
All-trans retinoic acid (ATRA) used for the treatment of APL can lead to the development of differentiation syndrome (DS), a potentially life threatening complication. Since ATRA is metabolized by cytochrome P450 (CYP) enzymes, we sought to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef8065649eb6ec99ff37f7f166bb36c3
https://doi.org/10.1016/j.leukres.2013.04.011
https://doi.org/10.1016/j.leukres.2013.04.011
Autor:
J. Andrew Skirvin
Publikováno v:
Oncology Times. 39:30-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::680f41e54c7a3ce0697ce090522d90d4
https://doi.org/10.1097/01.cot.0000528048.61963.f3
https://doi.org/10.1097/01.cot.0000528048.61963.f3
Autor:
J. Andrew Skirvin, Randi Kowalczyk
Publikováno v:
Oncology Times. 39:21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e564a951814232602a3afb63af74e9a
https://doi.org/10.1097/01.cot.0000521887.55083.19
https://doi.org/10.1097/01.cot.0000521887.55083.19
Autor:
J. Andrew Skirvin, Valerie Relias
Publikováno v:
Journal of Oncology Pharmacy Practice. 4:103-116
Purpose. The primary objective of this article is to discuss the pharmacology, pharmacokinetics, clinical use, and adverse effects of the approved topoisomer ase I inhibitors. This is the second in a series of two articles and will focus on irinoteca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::069fe1346874784c17823f82274a57c5
https://doi.org/10.1177/107815529800400202
https://doi.org/10.1177/107815529800400202
Publikováno v:
Journal of Oncology Pharmacy Practice. 4:117-120
Purpose. To describe a case of 6-mercaptopurine acute fulminate hepatotoxicity. Case Summary. A 65-year-old male with adult acute lymphocytic leukemia was receiving mainte nance therapy with 6-mercaptopurine and methotrex ate when he presented with j
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b698e30043e7c6443e3d58338f1fe11
https://doi.org/10.1177/107815529800400203
https://doi.org/10.1177/107815529800400203
Autor:
Valerie Relias, J. Andrew Skirvin
Publikováno v:
Journal of Oncology Pharmacy Practice. 3:173-185
Purpose. The primary objective of this article is to discuss the pharmacology, pharmacokinetics, clin ical use, and adverse effects of the approved topoisomerase I inhibitors. This is the first in a series of two articles and will focus on topotecan.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2725cc8ef5e454ff3d101b06a755aa50
https://doi.org/10.1177/107815529700300401
https://doi.org/10.1177/107815529700300401
Objective. To implement and assess the impact of a virtual patient pilot program on pharmacy students’ clinical competence skills. Design. Pharmacy students completed interactive software-based patient case scenarios embedded with drug-therapy prob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54bdad69c1b3cb208e7a6926af967c9
https://europepmc.org/articles/PMC3806956/
https://europepmc.org/articles/PMC3806956/
Publikováno v:
Critical reviews in oncology/hematology. 46(2)
Persons over the age of 65 years are the fastest growing segment of the United States population. In the next 30 years it will comprise over 20% of the population. Fifty percent of all cancers occur in this age group and therefore there will be an ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28bb99afe8bc95f98c55869ec11838a1
https://pubmed.ncbi.nlm.nih.gov/12711355
https://pubmed.ncbi.nlm.nih.gov/12711355
Autor:
Stuart M. Lichtman, J. Andrew Skirvin
Publikováno v:
Drugsaging. 19(1)
Persons over the age of 65 years are the fastest growing segment of the US population. In the next 30 years they will comprise over 20% of the population. Fifty per cent of all cancers occur in this age group and therefore there will be an expected r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6059c510a2f1b3aa9acaee3772ab21
https://pubmed.ncbi.nlm.nih.gov/11929325
https://pubmed.ncbi.nlm.nih.gov/11929325
Autor:
S M, Lichtman, J A, Skirvin
Publikováno v:
Oncology (Williston Park, N.Y.). 14(12)
The fastest growing segment of the US population is the group over the age of 65 years. In the next 30 years, this group will comprise over 20% of the population. Because 60% of all cancers occur in this age group, there will be an expected rise in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c923dc9bfdb3fd7a1265574f44594ecb
https://pubmed.ncbi.nlm.nih.gov/11204376
https://pubmed.ncbi.nlm.nih.gov/11204376